Diagnostics startup Droplet Biosciences partners with Nvidia to speed cancer test results

Diagnostics firm Droplet Biosciences said on Tuesday it is collaborating with Nvidia to use the chipmaker’s ​AI infrastructure to speed up post-surgery cancer test results.